NDC product
Abrysvo
NDC 0069-2465 · Pfizer Laboratories Div Pfizer Inc
Key facts
| Product NDC | 0069-2465 |
|---|---|
| Proprietary name | Abrysvo |
| Nonproprietary name | Respiratory Syncytial Virus Vaccine |
| Substances | RECOMBINANT STABILIZED RSV A PREFUSION F ANTIGEN, RECOMBINANT STABILIZED RSV B PREFUSION F ANTIGEN |
| Dosage form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAMUSCULAR |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Product type | VACCINE |
| Marketing category | BLA |
| Application number | BLA125769 |
| Marketing start | Jul 30, 2024 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: